Division of Infectious Diseases, Virginia Commonwealth University Medical Center, 1201 East Marshall Street, P.O. Box 980019, Richmond, Virginia 23298-0019, USA.
Clin Liver Dis. 2010 Feb;14(1):69-74; viii. doi: 10.1016/j.cld.2009.11.006.
The risk of acquiring hepatitis B and C in the oncology setting was historically high and predominantly related to blood product administration in the prescreening era. With the development of progressively more sophisticated testing for hepatitis B and C, breaches in infection control have played an increasingly prominent role in disease transmission. Optimizing infection control in inpatient and outpatient oncology settings is essential in preventing the health care-associated transmission of hepatitis B and C to oncology patients.
在肿瘤学环境中，感染乙型肝炎和丙型肝炎的风险历来较高，主要与筛查前时代血制品的使用有关。随着乙型肝炎和丙型肝炎检测技术的不断发展，感染控制方面的失误在疾病传播中发挥了越来越重要的作用。优化住院和门诊肿瘤学环境中的感染控制对于防止乙型肝炎和丙型肝炎在肿瘤患者中发生医源性传播至关重要。
